All In Biotech

Investigational drug · Phase 3

Tozorakimab

Also called: MEDI3506

Not approved by FDA. In 6 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Obstructive Pulmonary Disease (COPD), Asthma, Viral Lung Infection and Acute Respiratory Failure.

Phase 3

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

6

2 still active

All registered trials

10

Any phase or sponsor naming "Tozorakimab"

First trial start

2022

Jan 3, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Tozorakimab", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Viral Lung Infection and Acute Respiratory Failure

Approved drugs for the same conditions: Asthma · COPD · Infectious disease and vaccines · Respiratory

Largest trials

Live from ClinicalTrials.gov: studies naming "Tozorakimab" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 28 on PubMed

Also in development for Chronic Obstructive Pulmonary Disease (COPD)

  • HSK39004 DryPhase 34 trials

    Haisco Pharmaceutical Group Co., Ltd. · Chronic Obstructive Lung Disease (COLD), COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)

  • AstegolimabPhase 33 trials

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)

  • HSK31858Phase 33 trials

    Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis

  • HSK39004 Dry SimulantPhase 32 trials

    Haisco Pharmaceutical Group Co., Ltd. · COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)

  • JKN2401Phase 31 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)

  • PRA-216Phase 22 trials

    Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma

  • AZD6793Phase 21 trial

    AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD)

  • EXPD-101FXS7553Phase 21 trial

    Expedition Therapeutics, Inc · Chronic Obstructive Pulmonary Disease (COPD)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from AstraZeneca.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.